Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesFDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
The FDA is revising the prescribing information for the injectable diabetes medication exenatide and the oral diabetes drug sitagliptin phosphate following reports of renal problems associated with exenatide use, as well as reports linking sitagliptin use with pancreatitis.
Related Articles
Sitagliptin 100mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement
Current Medical Research and Opinion, 10/08/09
Relevance Score: 45%
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 44%
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 44%
Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation
Journal of Diabetes and its Complications, 10/29/09
Relevance Score: 43%
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 43%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/20/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Inflammation markers and metabolic characteristics of subjects with one-hour plasma glucose levels
Diabetes Care, 11/20/09
Indigenous Drugs in Ischemic Heart Disease in Patients with Diabetes
Journal of Alternative and Complementary Medicine, 11/20/09
Impact of Diastolic Dysfunction on the Development of Heart Failure in Diabetic Patients after Acute Myocardial Infarction
Circulation: Heart Failure, 11/20/09
Article Search
Sponsor